Accelmed Launches New $100M Venture Medtech Fund
Executive Summary
Israeli healthtech fund Accelmed is raising $100m for its fourth fund focused on medical device and digital health companies.
You may also be interested in...
Investor Eye: Israel’s Medical Device Fund Accelmed Seizes On Slow Medtech Investing
Israeli healthtech fund Accelmed is seizing the opportunity to implement a medtech-investment strategy that is delivering big returns. In this Medtech Insight feature, Irit Yaniv, partner at Israeli VC Accelmed, discusses changing trends in the medtech VC industry and the hot new areas of medical technology coming out of Israel.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.